Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-18 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2015-11-12 | New | $1,163,007 | $1,163,007 | Equity Only | 06b | SEC link |
| 2014-10-03 | New | $340,992 | $340,992 | Equity Only | 06b | SEC link |
| 2013-09-16 | New | $1,324,999 | $1,324,999 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Jeffrey Adam Galvin | Director, Executive |
| William Drew Palin | Director, Executive |
| Barry Haden Wells | Director |